A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma

NCT00434161 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

281

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Palifermin before only
DRUG: Placebo
DRUG: Palifermin before and after

Sponsor

Swedish Orphan Biovitrum